Brandy Albracht Hay

Brandy Albracht Hay is a seasoned Clinical Account Executive at ANI Pharmaceuticals, Inc. since December 2022, bringing extensive experience in the pharmaceutical industry. Previously, Brandy served as a Specialty Account Manager for Horizon Therapeutics, specializing in ophthalmology and orphan rare diseases, notably promoting Teprotumumab (Tepezza) for Thyroid Eye Disease. Prior roles include positions at Mallinckrodt Pharmaceuticals, focusing on Acthar Gel's promotion in complex orphan disease states, and Bayer, where Brandy successfully launched XOFIGO for metastatic prostate cancer. Brandy's career started with ENDO HEALTH SOLUTIONS as a Senior Territory Representative and earlier roles at Alcon Labs and Shire Pharmaceuticals. Brandy holds a Bachelor of Business Administration in Professional Selling from Baylor University and a Master of Business Administration from the University of Phoenix.